Interview with AmyriAD CEO Sharon L. Rogers

Sharon L. Rogers, PhD is leading the development of a new treatment for Alzheimer's. AmyriAD, where Sharon is CEO is in late stage trials for a drug that is designed to improve global function and cognition when used in combination with donepezil (Aricept).

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.